Isopto Hyoscine label

Isopto Hyoscine

Isopto Hyoscine Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Do not touch dropper tip to any surface, as this may contaminate the solution.

FOR TOPICAL OPHTHALMIC USE ONLY – NOT FOR INJECTION.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For mydriasis and cycloplegia in diagnostic procedures. For some pre- and postoperative states when a mydriatic and cycloplegic is needed in treatment of iridocyclitis.

History

There is currently no drug history available for this drug.

Other Information

ISOPTO® Hyoscine (scopolamine hydrobromide ophthalmic solution) is an anticholinergic prepared as a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structure:

Chemical Diagram

Established name: scopolamine hydrobromide
Chemical name: benzeneacetic acid, α-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, hydrobromide, trihydrate, [7(S)-(1α,2β,4β,5α,7β)]-.

Each mL contains: Active: scopolamine hydrobromide 0.25%. Preservative: benzalkonium chloride 0.01%. Vehicle: hypromellose 0.5%. Inactives: sodium chloride, glacial acetic acid, sodium acetate (to adjust pH), purified water.

Isopto Hyoscine Manufacturers

  • Isopto Hyoscine | Alcon Laboratories, Inc.
    No Recall

    Isopto Hyoscine | Alcon Laboratories, Inc.

    Isopto Hyoscine | Alcon Laboratories, Inc.

    For refraction, administer one or two drops in the eye(s) one hour before refracting. For uveitis, administer one or two drops in the eye(s) up to four times daily.